Webinar | March 14, 2019

Standing Out In The Crowded Biopharmaceutical Contract Manufacturing Market

Source: ISR Reports

Differentiating one’s CDMO offering from competitors is an essential component of gaining awareness, familiarity, and being awarded business. When CDMOs understand what motivates drug innovators to outsource, who is involved in the service provider selection decision, and which CDMO attributes have the greatest influence on CDMO selection they are able to communicate what is unique about their offering to the right audience at the right time. 

Join ISR as we share data and insights from our CDMO Quality Benchmarking reports that will help CMOs to better understand how to move their position in the competitive landscape. ISR will provide CDMOs with methods to differentiate their service offering from competitors as well as how to develop marketing based on true areas of strength. Additionally, we will have a look at how brand strength and service provider performance correspond with industry perceptions of leadership and how this knowledge should influence your sales pitches.

VIEW THE WEBINAR!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Biosimilar Development? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: